<DOC>
	<DOCNO>NCT02122692</DOCNO>
	<brief_summary>To examine effect strong CYP3A4/5 inhibitor itraconazole ( 200 mg QD ) multipledose exposure Lu AE58054 ( 30 mg QD ) healthy subject ( CYP2D6 extensive metabolisers ) .</brief_summary>
	<brief_title>Effect Multiple Doses Itraconazole Multiple Dose Pharmacokinetics Lu AE58054 Healthy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Itraconazole</mesh_term>
	<mesh_term>Hydroxyitraconazole</mesh_term>
	<criteria>Subjects eligible inclusion study meet follow criterion : Men woman , age 18 45 year . Body weight least 50 kg Body Mass index 19 28 kg/m2 . Good general health ascertain detailed medical history , laboratory test physical examination . Nonchildbearing potential use contraception ( sex ) . Women must pregnant lactating . Known CYP2D6 genotype ( Extensive metaboliser ( n=15 ) poor metaboliser ( n =5 ) ) . Other Inclusion Exclusion Criteria may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>June 2014</verification_date>
</DOC>